VitaPCR™ is an accurate and rapid molecular diagnostic solution that detects infectious diseases in just 20 minutes using real-time Polymerase Chain Reaction (real-time PCR) technology. It complements other laboratory-based methods and conventional lab testing, empowering laboratory and healthcare professionals with highly accurate ...

VitaPCR™ SARS-CoV-2 Gen 2 Assay based on the proprietary RT-PCR technology provides significantly faster testing results than any other laboratory-based methods with higher accuracy than conventional rapid testing. With less than a minute of hands-on time, the test allows the detection of SARS-CoV-2 in 20 minutes from sample to results.

Combining a simplified 1 minute hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design without the need for extra equipment like refrigeration, and a proprietary RT-PCR technology allowing fast and accurate diagnostics; VitaPCR™ allows the detection of Influenza and SARS-CoV-2 in ...

La puissance de la biologie moléculaire pour la détection des principaux virus respiratoires au plus près des patients. VitaPCR™ est un système innovant qui réalise en 20 minutes une PCR en temps réel permettant la détection du SARS-CoV-2, d’Influenza A & B, et du virus RSV directement à partir d’écouvillons nasopharyngés.

With its 20 minutes response time, combined with sensitivity levels very close to Laboratory PCR, the VitaPCR™ SARS-CoV-2 Gen2 rapid Real Time PCR test is the ideal solution for monitoring both symptomatic and asymptomatic patients at the point of …

2023年8月1日 · The CE-marked PCR assay is based on real-time reverse transcription polymerase chain reaction (RT-PCR) technology without prior RNA extraction and captures 2 RNA target sequences of the nucleocapsid region (N) - a conserved SARS-like RNA region and a more specific SARS-CoV-2 RNA sequence - as well as …

rapid RT-PCR test is used for the qualitative detection and discrimination of Influenza A, Influenza B and SARS-CoV-2 viral RNA in nasopharyngeal swabs from patients with signs and symptoms of respiratory infection. Results are also available in 20 minutes. Other swab specimen tests: VitaPCR Influenza/RSV Assay (nasal or nasopharyngeal swab)

2023年1月9日 · This study suggests that the VitaPCR™ can allow the rapid management of patients within the Emergency Department. Nevertheless, it is advisable to obtain a negative result by a RT-PCR assay before admitting a patient to a regular ward.

The VitaPCRTM SARS-CoV-2 Gen 2 Assay performed on the VitaPCRTM Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction (RT-PCR) amplification technology for the qualitative detection of Coronavirus Disease 2019 (COVID-19) viral RNA in nasopharyngeal (NP) or oropharyngeal (OP...

Methods: In this prospective study 6642 oropharyngeal swabs from nonpreselected ED patients were tested for SARS-CoV-2 with (1) extraction-free VitaPCR and (2) extraction-based reference assays (Aptima®, cobas®, Xpert®Xpress). Results: The median TAT of VitaPCR was 47 minutes (IQR: 38-59), while reference assays required 6.2 hours (IQR: 4.4-13.3).